ASM Microbe 2026
June 4-7, 2026 – Washington, DC, USA
ADLM 2026
July 26-30, 2026 – Anaheim, CA, USA

HPV vs Herpes

Sexually transmitted infections (STIs) continue to be a significant global health concern. Among the most common STIs are Human Papillomavirus (HPV) and herpes. They can cause genital lesions, but they can also be asymptomatic. However, HPV is much more prevalent than herpes. Almost every sexually active person will encounter HPV at least once, and may even be infected with both viruses simultaneously.

What is HPV?

Human Papillomavirus (HPV) is a highly prevalent STI, affecting millions of people worldwide. It is primarily transmitted through sexual contact, including vaginal, anal, and oral sex. HPV infection often goes unnoticed, as it can be asymptomatic, leading to its classification as a "silent" infection.

Symptoms of HPV: There are over 100 different strains of HPV, with some causing genital warts and others posing a higher risk of cancer. The most common high-risk types include HPV-16 and HPV-18, responsible for the majority of cervical cancer cases.

Low-risk types, such as HPV-6 and HPV-11, are associated with genital warts. Genital warts can develop on the penis, scrotum, anus, vagina, vulva, and cervix. These genital warts can occur as:

  • Single growth
  • Cluster of growths
  • Growths with a cauliflower-like appearance
  • The HPV that causes genital warts also causes warts in the mouth and throat. This is called oral HPV.

Learn more about Human Papillomvirus Antigens

The natural HPV infection can lead to cervical cancer.Figure 1. The natural HPV infection can lead to cervical cancer.
(Source: Yousefi, Z. et al., 2022)

What is Herpes?

Herpes is another common STI caused by the herpes simplex virus (HSV). It exists in two forms: HSV-1 and HSV-2. While HSV-1 is typically associated with oral herpes (cold sores), HSV-2 is primarily responsible for genital herpes. Herpes infection is lifelong, with periods of active outbreaks and asymptomatic periods.

Learn more about Herpes Simplex Virus Antigens

Symptoms of Herpes: Herpes is transmitted through direct contact with infected skin or mucous membranes. During active outbreaks, characterized by painful blisters or sores, the virus is highly contagious. However, even during asymptomatic periods, the virus can still be transmitted, making prevention challenging.

Herpes blisters may appear around the vagina, vulva, inside of the thighs, anus, and penis. Symptoms associated with genital herpes usually include:

  • Itching
  • Pain around the genitals
  • A burning feeling when a person pees

Comparing HPV and Herpes

HPVHerpes
Transmission ChannelsSkin-to-skin contact with an infected person, including vaginal, anal, or oral sex.Skin or saliva contact with an infected person, including vaginal, anal, or oral sex.
Key SymptomsWarts are the most common symptom. However, HPV infection is usually clinically asymptomatic.Herpes may also be asymptomatic but usually manifests as oozing sores or blisters, or itching or pain shortly after infection.
Rarity~75-80% of population has HPV~90% of population has HSV1
~16% has HSV-2
Diagnostic toolsHPV testing exists and is sometimes used in Pap tests. Otherwise, visual inspection of warts can diagnose some cases.If lesions are present, a physical examination is often performed. A swab is usually used to collect a sample, and viral cultures are used for diagnosis.
TreatmentThe virus itself can't be cured, but medications for treating genital warts can be used to remove warts and diseases can be prevented through health checks for high-risk HPV.Although the virus itself can't be cured, antiviral drugs can treat symptoms or reduce outbreaks.
PreventionPracticing safe sex and getting routine screenings, especially for cancer cervical cancer, can greatly reduce the risk.Practicing safe sex, not only vaginal or anal sex but also oral sex, can greatly prevent herpes.

How to Treat HPV

HPV cannot be cured but can be treated. HPV vaccines like Gardasil protect against future HPV infections, especially when administered during early adolescence. In the case of HPV infection, the most noticeable effect is the development of genital warts, which may resolve on their own. However, prescription medications are available to treat persistent warts if necessary.

Understand HPV Vaccine

The mechanisms of action of HPV vaccines.Figure 2. The mechanisms of action of HPV vaccines.
(Source: Boda, D. et al., 2018)

Moreover, abnormal cell changes caused by HPV can be treated to prevent the progression of cancer. However, this treatment is typically effective only if the individual is aware of their HPV infection. Early detection through testing plays a crucial role in identifying and managing HPV-related cancers, ensuring timely intervention to prevent further development.

How to Treat Herpes

Herpes, similar to HPV, cannot be cured but the symptoms can be treated. In the case of visible symptoms such as cold sores or genital herpes, treatment options are available. For cold sores, which typically resolve within seven to 10 days, treatment can help alleviate symptoms and expedite healing. This may involve the use of antiviral tablets, antiviral creams, cold sore patches, or non-antiviral medications. Genital herpes symptoms will also clear up on their own, but treatment can help shorten outbreaks, prevent symptom aggravation, and provide relief. Antiviral medications are commonly prescribed for genital herpes, and creams may be used to alleviate pain and discomfort.

By seeking appropriate treatment, individuals can manage the symptoms of herpes, reduce the duration and severity of outbreaks, and alleviate discomfort associated with the infection.

How to Prevent STIs

Reducing the risk of contracting sexually transmitted infections (STIs) involves several important strategies.

  • Using barrier protection, such as condoms, female condoms, or dental dams during sexual activity.
  • Regular STI testing is crucial, particularly when engaging in sexual activities with new partners or between partners.
  • Open and honest communication about sexual health status is essential.
  • Considering the availability of the HPV vaccine, getting vaccinated is a proactive approach to reducing the risk of HPV infection. The HPV vaccine protects against certain high-risk strains of the virus that can lead to cervical, anal, and other types of cancers.

By following these preventive measures, individuals can take control of their sexual health and minimize the risk of contracting STIs, including HPV and herpes.

References

  1. Yousefi Z, et al. An update on human papilloma virus vaccines: history, types, protection, and efficacy. Frontiers in Immunology. 2022, 12: 805695.
  2. Boda D, et al. Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues. International Journal of Oncology. 2018, 52(3): 637-655.
  3. Dunne E F, Park I U. HPV and HPV-associated diseases. Infectious Disease Clinics. 2013, 27(4): 765-778.
  4. Marlow L A V, et al. Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison. Vaccine. 2013, 31(5): 763-769.
  5. James C, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bulletin of the World Health Organization. 2020, 98(5): 315.

HPV Antibodies

HPV Antigens

TargetCat. No.Product NameExpression SystemTag/ConjugateApplication
HPVPSVG-HPV16Pseudotyped GFP HPV16Useful for studying papillomavirus assembly, entry, and neutralization.Inquiry
PSVG-HPV18Pseudotyped GFP HPV18Useful for studying papillomavirus assembly, entry, and neutralization.Inquiry
PSVG-HPV31Pseudotyped GFP HPV31Useful for studying papillomavirus assembly, entry, and neutralization.Inquiry
PSVG-HPV33Pseudotyped GFP HPV33Useful for studying papillomavirus assembly, entry, and neutralization.Inquiry
PSVG-HPV39Pseudotyped GFP HPV39Useful for studying papillomavirus assembly, entry, and neutralization.Inquiry
PSVG-HPV45Pseudotyped GFP HPV45Useful for studying papillomavirus assembly, entry, and neutralization.Inquiry
HPV 11DAGF-228Recombinant Human Papilloma Virus type 11 L1 protein (VLP)E. coliUnconjugatedInquiry
DAG1576Recombinant HPV type 11 [GST]E. coliGSTN/AInquiry
HPV 35DAGC142Recombinant Human Papilloma Virus type 35 L1 protein (VLP)E. coliUnconjugatedSDS-PAGEInquiry
HPV 39DAGC143Recombinant Human Papilloma Virus type 39 L1 protein (VLP)E. coliUnconjugatedSDS-PAGEInquiry
HPV16DAGF-094Recombinant HPV16 E6 protein [His]E. coliHisInquiry
DAGF-095Recombinant HPV16 E6 protein (aa 1-158) [His]YeastHisInquiry
DAGF-096Recombinant HPV16 E7 protein (aa 1-98) [GST]E. coliGSTInquiry
DAGF-229Recombinant Human Papilloma Virus type 16 L1 protein (VLP)E. coliUnconjugatedInquiry
DAG-P2512Recombinant HPV type 16 (aa 1 - 531)E. coliUnconjugatedSDS-PAGEInquiry

More HSV Antibodies

HSV Antigens

TargetCat. No.Product NameExpression SystemTag/ConjugateApplication
HSVDAGC433Inactivated HSV Type 1 AntigenN/AUnconjugatedInquiry
DAGC434Inactivated HSV Type 2 AntigenN/AUnconjugatedInquiry
DAGA-547Herpes simplex virus 2 (strain G)Vero cellsUnconjugatedN/AInquiry
DAGA-546Herpes simplex virus 1 (strain F)Vero cellsUnconjugatedN/AInquiry
DAGA-613HSV-2 gG peptideE. coliTBDWB, ELISAInquiry
HSV 2DAGA-443Recombinant Herpes Simplex Virus-2 VP22 Protein [His]E. coliUnconjugatedELISA, WBInquiry
DAGA-3075Recombinant HSV-2 gC(Ectodomain) [His]HEK293HisWB, ELISAInquiry
DAGA-442Native HSV type 2 gGVero CellsUnconjugatedELISAInquiry
DAGA-444Recombinant HSV type 2 VP13/14E. coliUnconjugatedELISA, WBInquiry
DAGA-445Recombinant HSV type 2 gD (Glycosylated)P. pastorisUnconjugatedELISA, WBInquiry
HSV1DAG3131Native HSV Type 1 Grade III AntigenVero CellsUnconjugatedELISAInquiry
DAG3232Native HSV type 1 Infected Cell ExtractUnconjugatedELISA, WBInquiry
DAG3091Native HSV type 1 MacIntyreN/AUnconjugatedELISA, WBInquiry
DAG589Recombinant HSV type 1 Glycosylated (a.a. 21-339) [His]P. pastorisHisELISA, WBInquiry
DAG179Native HSV type 1N/AUnconjugatedELISAInquiry

More HSV Antigens

HSV ELISA Kits

TargetCat. No.Product NameSizeSpecies ReactivityApplicationDetection Sample
HSVDEIA344Herpes 1 IgG ELISA Kit96THumanQuantitativeserum, plasmaInquiry
DEIA345Human Herpes Simplex Virus1 IgA (HSV-1 IgA) ELISA Test kit96THumanQualitativeSerumInquiry
DEIA346Herpes 1 IgM ELISA Kit96THumanQuantitativeserum, plasmaInquiry
DEIA347Herpes 2 IgG ELISA Kit96THumanQuantitativeserum, plasmaInquiry
DEIA348Herpes 2 IgA ELISA Kit96THumanQuantitativeserum, plasmaInquiry
DEIA349Herpes simplex Virus 2 (HSV 2) IgM ELISA96THumanQualitativeSerum or plasma (citrate, heparin)Inquiry
DEIA351Human Herpes 1/2 IgA ELISA kit96THumanQuantitativeserum, plasma or cerebrospinal fluidInquiry
DEIA547HSV IgM ELISA Kit96THumanQualitativeserum, plasmaInquiry
DEIA05535HSV Type 1 rec. gG1 IgG-ELISA Kit96THumanQualitativeserum, citrate plasmaInquiry
DEIA05537HSV Type 2 rec. gG2 IgG-ELISA Kit96THumanQualitativeserum, citrate plasmaInquiry
DEIA3555Mouse/Rat HSV-1 IgG ELISA Kit96TMouse, RatQualitativeserum, plasmaInquiry
DEIA1715HSV-1 and HSV-2 IgM ELISA Kit96THumanqualitativeserumInquiry
HSV-1/2DEIA350Herpes 1/2 IgG ELISA kit96THumanQuantitativeSerum, plasma, cerebrospinal fluidInquiry
DEIA352Herpes 1/2 IgM ELISA kit96THumanQuantitativeSerum, plasma, cerebrospinal fluidInquiry
Inquiry Basket